Quanterix shares rise 12.69% intraday after acquiring Akoya Biosciences to create integrated protein biomarker ecosystem.

Quanterix surged 12.69% intraday after announcing its acquisition of Akoya Biosciences, creating the first integrated ecosystem for ultra-sensitive biomarker detection in both liquid and tissue samples. The deal combines Akoya’s spatial biology capabilities with Quanterix’s advanced detection tools, positioning the company to expand its offerings in precision diagnostics and life sciences research. The market reaction reflects optimism about the strategic synergy and enhanced technological leadership in the growing biomarker analysis sector.